Email this article to a friend
BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
-
* Corresponding author: Thomas Reithmeier thomas.reithmeier@uniklinik-freiburg.de
BMC Cancer 2010, 10:30 doi:10.1186/1471-2407-10-30